全文获取类型
收费全文 | 1259篇 |
免费 | 110篇 |
出版年
2021年 | 9篇 |
2019年 | 12篇 |
2017年 | 12篇 |
2016年 | 18篇 |
2015年 | 30篇 |
2014年 | 34篇 |
2013年 | 50篇 |
2012年 | 50篇 |
2011年 | 55篇 |
2010年 | 39篇 |
2009年 | 33篇 |
2008年 | 54篇 |
2007年 | 52篇 |
2006年 | 43篇 |
2005年 | 48篇 |
2004年 | 47篇 |
2003年 | 36篇 |
2002年 | 41篇 |
2001年 | 39篇 |
2000年 | 32篇 |
1999年 | 37篇 |
1998年 | 17篇 |
1997年 | 13篇 |
1996年 | 16篇 |
1995年 | 19篇 |
1994年 | 8篇 |
1993年 | 17篇 |
1992年 | 25篇 |
1991年 | 28篇 |
1990年 | 22篇 |
1989年 | 18篇 |
1988年 | 18篇 |
1987年 | 22篇 |
1986年 | 17篇 |
1985年 | 17篇 |
1984年 | 16篇 |
1983年 | 22篇 |
1982年 | 19篇 |
1981年 | 16篇 |
1980年 | 12篇 |
1979年 | 23篇 |
1978年 | 13篇 |
1977年 | 16篇 |
1976年 | 16篇 |
1975年 | 20篇 |
1974年 | 18篇 |
1973年 | 11篇 |
1972年 | 8篇 |
1969年 | 9篇 |
1968年 | 10篇 |
排序方式: 共有1369条查询结果,搜索用时 15 毫秒
91.
92.
93.
94.
95.
96.
97.
Andrea Jegerlehner Franziska Zabel Alice Langer Klaus Dietmeier Gary T. Jennings Philippe Saudan Martin F. Bachmann 《PloS one》2013,8(11)
Although current influenza vaccines are effective in general, there is an urgent need for the development of new technologies to improve vaccine production timelines, capacities and immunogenicity. Herein, we describe the development of an influenza vaccine technology which enables recombinant production of highly efficient influenza vaccines in bacterial expression systems. The globular head domain of influenza hemagglutinin, comprising most of the protein''s neutralizing epitopes, was expressed in E. coli and covalently conjugated to bacteriophage-derived virus-like particles produced independently in E.coli. Conjugate influenza vaccines produced this way were used to immunize mice and found to elicit immune sera with high antibody titers specific for the native influenza hemagglutinin protein and high hemagglutination-inhibition titers. Moreover vaccination with these vaccines induced full protection against lethal challenges with homologous and highly drifted influenza strains. 相似文献
98.
Haifeng Song Krisztina Janosko Reed F. Johnson Jing Qin Nicole Josleyn Catherine Jett Russell Byrum Marisa St. Claire Julie Dyall Joseph E. Blaney Gerald Jennings Peter B. Jahrling 《PloS one》2013,8(4)
Infection of non-human primates (NHPs) such as rhesus and cynomolgus macaques with monkeypox virus (MPXV) or cowpox virus (CPXV) serve as models to study poxvirus pathogenesis and to evaluate vaccines and anti-orthopox therapeutics. Intravenous inoculation of macaques with high dose of MPXV (>1–2×107 PFU) or CPXV (>102 PFU) results in 80% to 100% mortality and 66 to 100% mortality respectively. Here we report that NHPs with positive detection of poxvirus antigens in immune cells by flow cytometric staining, especially in monocytes and granulocytes succumbed to virus infection and that early positive pox staining is a strong predictor for lethality. Samples from four independent studies were analyzed. Eighteen NHPs from three different experiments were inoculated with two different MPXV strains at lethal doses. Ten NHPs displayed positive pox-staining and all 10 NHPs reached moribund endpoint. In contrast, none of the three NHPs that survived anticipated lethal virus dose showed apparent virus staining in the monocytes and granulocytes. In addition, three NHPs that were challenged with a lethal dose of MPXV and received cidofovir treatment were pox-antigen negative and all three NHPs survived. Furthermore, data from a CPXV study also demonstrated that 6/9 NHPs were pox-antigen staining positive and all 6 NHPs reached euthanasia endpoint, while the three survivors were pox-antigen staining negative. Thus, we conclude that monitoring pox-antigen staining in immune cells can be used as a biomarker to predict the prognosis of virus infection. Future studies should focus on the mechanisms and implications of the pox-infection of immune cells and the correlation between pox-antigen detection in immune cells and disease progression in human poxviral infection. 相似文献
99.
Michael J. Herr Jayaprakash Kotha Nikolaus Hagedorn Blake Smith Lisa K. Jennings 《PloS one》2013,8(6)
Tumor cell metastasis, a process which increases the morbidity and mortality of cancer patients, is highly dependent upon matrix metalloproteinase (MMP) production. Small molecule inhibitors of MMPs have proven unsuccessful at reducing tumor cell invasion in vivo. Therefore, finding an alternative approach to regulate MMP is an important endeavor. Tetraspanins, a family of cell surface organizers, play a major role in cell signaling events and have been implicated in regulating metastasis in numerous cancer cell lines. We stably expressed tetraspanin CD9 in an invasive and metastatic human fibrosarcoma cell line (CD9-HT1080) to investigate its role in regulating tumor cell invasiveness. CD9-HT1080 cells displayed a highly invasive phenotype as demonstrated by matrigel invasion assays. Statistically significant increases in MMP-9 production and activity were attributed to CD9 expression and were not due to any changes in other key tetraspanin complex members or MMP regulators. Increased invasion of CD9-HT1080 cells was reversed upon silencing of MMP-9 using a MMP-9 specific siRNA. Furthermore, we determined that the second extracellular loop of CD9 was responsible for the upregulation of MMP-9 production and subsequent cell invasion. We demonstrated for the first time that tetraspanin CD9 controls HT1080 cell invasion via upregulation of an integral member of the MMP family, MMP-9. Collectively, our studies provide mounting evidence that altered expression of CD9 may be a novel approach to regulate tumor cell progression. 相似文献
100.
Jolanta Krudysz-Amblo Mark E. Jennings II Tyler Knight Dwight E. Matthews Kenneth G. Mann Saulius Butenas 《Biochimica et Biophysica Acta (BBA)/General Subjects》2013